Speaker

Juanjo Cragnolini

Associate Director, Oncology Search & Evaluation, Takeda Pharmaceutical

Juanjo Cragnolini, Associate Director, Oncology Search & Evaluation at Takeda Pharmaceutical, spoke at Oncology & Immunology Innovation Partnering & Licensing Summit (Boston, United States of America, 9–10 Sept 2026) in the session “Pharma Icebreaker Panel Discussion: Targeted Oncology Biologics”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Oncology & Cancer Research

Past appearances

Oncology & Immunology Innovation Partnering & Licensing Summit
9–10 Sept 2026Boston, United States of America
- PanelPharma Icebreaker Panel Discussion: Targeted Oncology BiologicsWith Michael Torres, Carla Bauer, Matthew Posluszny, Anu Connor, Hong Xin, Xiaodong Zhang, Ayano Takeuchi, Akihiro Furukawa

More speakers at Oncology & Immunology Innovation Partnering & Licensing Summit

Adam Gilbert
Science Partner, Flagship Pioneering
Mike Jones
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Jason Kantor
Chief Business Officer, Nurix Therapeutics, Inc.
Nikhil Mutyal
Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca
Giovanni Spagnolli
Co-Founder & Chief Technology Officer, Sibylla Biotech srl
Dori Thomas-Karyat
Chief Executive Officer, Synthis Therapeutics

See all 50 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Juanjo Cragnolini, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].